NEW YORK (GenomeWeb News) – Stratagene yesterday said that VWR International will distribute its “full line” of research products in Canada beginning in October.
Under the terms of the agreement, Stratagene and VWR will service Canadian customers in an “integrated manner.” For example, Stratagene will continue to support Canadian customers with direct sales representation and field applications support in the country and provide technical support and instrument service from its US offices.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.

The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.

Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.

In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.